1. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008; 51:1419–1428. PMID:
18402894.
Article
2. Li LP, Lu J, Zhou Y, Papadopoulou MV, Franklin T, Bokhary U, et al. Evaluation of intrarenal oxygenation in iodinated contrast-induced acute kidney injury-susceptible rats by blood oxygen level-dependent magnetic resonance imaging. Invest Radiol. 2014; 49:403–410. PMID:
24566288.
Article
3. Calvin AD, Misra S, Pflueger A. Contrast-induced acute kidney injury and diabetic nephropathy. Nat Rev Nephrol. 2010; 6:679–688. PMID:
20877303.
Article
4. Stacul F, van der Molen AJ, Reimer P, Webb JA, Thomsen HS, Morcos SK, Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR), et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011; 21:2527–2541. PMID:
21866433.
Article
5. Chalikias G, Drosos I, Tziakas DN. Contrast-induced acute kidney injury: an update. Cardiovasc Drugs Ther. 2016; 30:215–228. PMID:
26780748.
Article
6. Kurnik BR, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis. 1998; 31:674–680. PMID:
9531185.
Article
7. Su J, Zou W, Cai W, Chen X, Wang F, Li S, et al. Atorvastatin ameliorates contrast medium-induced renal tubular cell apoptosis in diabetic rats via suppression of rho-kinase pathway. Eur J Pharmacol. 2014; 723:15–22. PMID:
24445019.
Article
8. Li LP, Lu J, Franklin T, Zhou Y, Solomon R, Prasad PV. Effect of iodinated contrast medium in diabetic rat kidneys as evaluated by blood-oxygenation-level-dependent magnetic resonance imaging and urinary neutrophil gelatinase-associated lipocalin. Invest Radiol. 2015; 50:392–396. PMID:
25668748.
Article
9. Inoue T, Kozawa E, Okada H, Inukai K, Watanabe S, Kikuta T, et al. Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging. J Am Soc Nephrol. 2011; 22:1429–1434. PMID:
21757771.
Article
10. dos Santos EA, Li LP, Ji L, Prasad PV. Early changes with diabetes in renal medullary hemodynamics as evaluated by fiberoptic probes and BOLD magnetic resonance imaging. Invest Radiol. 2007; 42:157–162. PMID:
17287645.
Article
11. Hueper K, Hartung D, Gutberlet M, Gueler F, Sann H, Husen B, et al. Assessment of impaired vascular reactivity in a rat model of diabetic nephropathy: effect of nitric oxide synthesis inhibition on intrarenal diffusion and oxygenation measured by magnetic resonance imaging. Am J Physiol Renal Physiol. 2013; 305:F1428–F1435. PMID:
24005471.
Article
12. Liang L, Chen WB, Chan KW, Li YG, Zhang B, Liang CH, et al. Using intravoxel incoherent motion MR imaging to study the renal pathophysiological process of contrast-induced acute kidney injury in rats: comparison with conventional DWI and arterial spin labelling. Eur Radiol. 2016; 26:1597–1605. PMID:
26373761.
Article
13. Cai XR, Yu J, Zhou QC, Du B, Feng YZ, Liu XL. Use of intravoxel incoherent motion MRI to assess renal fibrosis in a rat model of unilateral ureteral obstruction. J Magn Reson Imaging. 2016; 44:698–706. PMID:
26841951.
Article
14. Ichikawa S, Motosugi U, Ichikawa T, Sano K, Morisaka H, Araki T. Intravoxel incoherent motion imaging of the kidney: alterations in diffusion and perfusion in patients with renal dysfunction. Magn Reson Imaging. 2013; 31:414–417. PMID:
23102943.
Article
15. Ding Y, Zeng M, Rao S, Chen C, Fu C, Zhou J. Comparison of biexponential and monoexponential model of diffusion-weighted imaging for distinguishing between common renal cell carcinoma and fat poor angiomyolipoma. Korean J Radiol. 2016; 17:853–863. PMID:
27833401.
Article
16. Wang Y, Ren K, Liu Y, Sun WG, Wang JH, Zhang X, et al. Application of BOLD MRI and DTI for the evaluation of renal effect related to viscosity of iodinated contrast agent in a rat model. J Magn Reson Imaging. 2017; 46:1320–1331. PMID:
28248433.
Article
17. Heyman SN, Rosen S, Rosenberger C. Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol. 2008; 3:288–296. PMID:
18057308.
Article
18. Rosenberger C, Heyman SN, Rosen S, Shina A, Goldfarb M, Griethe W, et al. Up-regulation of HIF in experimental acute renal failure: evidence for a protective transcriptional response to hypoxia. Kidney Int. 2005; 67:531–542. PMID:
15673301.
Article
19. Shukla R, Pandey N, Banerjee S, Tripathi YB. Effect of extract of Pueraria tuberosa on expression of hypoxia inducible factor-1α and vascular endothelial growth factor in kidney of diabetic rats. Biomed Pharmacother. 2017; 93:276–285. PMID:
28648975.
Article
20. Manotham K, Tanaka T, Ohse T, Kojima I, Miyata T, Inagi R, et al. A biologic role of HIF-1 in the renal medulla. Kidney Int. 2005; 67:1428–1439. PMID:
15780095.
Article
21. Rosenberger C, Griethe W, Gruber G, Wiesener M, Frei U, Bachmann S, et al. Cellular responses to hypoxia after renal segmental infarction. Kidney Int. 2003; 64:874–886. PMID:
12911537.
Article
22. Zhao Q, Li J, Yan J, Liu S, Guo Y, Chen D, et al. Lycium barbarum polysaccharides ameliorates renal injury and inflammatory reaction in alloxan-induced diabetic nephropathy rabbits. Life Sci. 2016; 157:82–90. PMID:
27262790.
Article
23. Papadimitriou A, Silva KC, Peixoto EB, Borges CM, Lopes de, Lopes de. Theobromine increases NAD
+/Sirt-1 activity and protects the kidney under diabetic conditions. Am J Physiol Renal Physiol. 2015; 308:F209–F225. PMID:
25411384.
24. Pettersson G, Towart R, Grant D, Thyberg K, Golman K. The rabbit renal toxicity test: a sensitive in vivo test for the nephrotoxicity of contrast agents. Acad Radiol. 2002; 9(Suppl 1):S62–S64. PMID:
12019897.
25. Lauver DA, Carey EG, Bergin IL, Lucchesi BR, Gurm HS. Sildenafil citrate for prophylaxis of nephropathy in an animal model of contrast-induced acute kidney injury. PLoS One. 2014; 9:e113598. PMID:
25426714.
Article
26. Wang JH, Ren K, Sun WG, Zhao L, Zhong HS, Xu K. Effects of iodinated contrast agents on renal oxygenation level determined by blood oxygenation level dependent magnetic resonance imaging in rabbit models of type 1 and type 2 diabetic nephropathy. BMC Nephrol. 2014; 15:140. PMID:
25182068.
Article
27. Vivier PH, Storey P, Chandarana H, Yamamoto A, Tantillo K, Khan U, et al. Renal blood oxygenation level–dependent imaging contribution of R2 to R2* values. Invest Radiol. 2013; 48:501–508. PMID:
23385400.
28. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988; 168:497–505. PMID:
3393671.
Article
29. Tsamouri MM, Rapti M, Kouka P, Nepka C, Tsarouhas K, Soumelidis A, et al. Histopathological evaluation and redox assessment in blood and kidney tissues in a rabbit contrast-induced nephrotoxicity model. Food Chem Toxicol. 2017; 108(Pt A):186–193. PMID:
28774741.
Article
30. Ari E, Kedrah AE, Alahdab Y, Bulut G, Eren Z, Baytekin O, et al. Antioxidant and renoprotective effects of paricalcitol on experimental contrast-induced nephropathy model. Br J Radiol. 2012; 85:1038–1043. PMID:
22815410.
Article
31. Wang Y, Ren K, Xie L, Sun W, Liu Y, Li S. Effect of repeated injection of iodixanol on renal function in healthy Wistar rats using functional MRI. Biomed Res Int. 2018; 2018:7272485. PMID:
29850557.
Article
32. Ries M, Basseau F, Tyndal B, Jones R, Deminière C, Catargi B, et al. Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J Magn Reson Imaging. 2003; 17:104–113. PMID:
12500279.
33. Cheung JS, Fan SJ, Gao DS, Chow AM, Man K, Wu EX. Diffusion tensor imaging of liver fibrosis in an experimental model. J Magn Reson Imaging. 2010; 32:1141–1148. PMID:
21031520.
Article
34. Wang J, Zhang Y, Yang X, Wang X, Zhang J, Fang J, et al. Time course study on the effects of iodinated contrast medium on intrarenal water transport function using diffusion-weighted MRI. J Magn Reson Imaging. 2012; 35:1139–1144. PMID:
22247072.
Article
35. Yan YY, Hartono S, Hennedige T, Koh TS, Chan CM, Zhou L, et al. Intravoxel incoherent motion and diffusion tensor imaging of early renal fibrosis induced in a murine model of streptozotocin induced diabetes. Magn Reson Imaging. 2017; 38:71–76. PMID:
28038964.
Article
36. Nakagawa T, Sato W, Kosugi T, Johnson RJ. Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy. J Diabetes Res. 2013; 2013:184539. PMID:
24386643.
Article
37. Rauch D, Drescher P, Pereira FJ, Knes JM, Will JA, Madsen PO. Comparison of iodinated contrast media-induced renal vasoconstriction in human, rabbit, dog, and pig arteries. Invest Radiol. 1997; 32:315–319. PMID:
9179705.
Article
38. Heyman SN, Rosenberger C, Rosen S, Khamaisi M. Why is diabetes mellitus a risk factor for contrast-induced nephropathy? Biomed Res Int. 2013; 2013:123589. PMID:
24350240.
Article
39. Melin J, Hellberg O, Akyürek LM, Källskog O, Larsson E, Fellström BC. Ischemia causes rapidly progressive nephropathy in the diabetic rat. Kidney Int. 1997; 52:985–991. PMID:
9328937.
Article
40. Goldfarb M, Rosenberger C, Abassi Z, Shina A, Zilbersat F, Eckardt KU, et al. Acute-on-chronic renal failure in the rat: functional compensation and hypoxia tolerance. Am J Nephrol. 2006; 26:22–33. PMID:
16508244.
Article
41. Prasad P, Li LP, Halter S, Cabray J, Ye M, Batlle D. Evaluation of renal hypoxia in diabetic mice by BOLD MRI. Invest Radiol. 2010; 45:819–822. PMID:
20829708.
Article
42. Basile DP, Donohoe DL, Roethe K, Mattson DL. Chronic renal hypoxia after acute ischemic injury: effects of L-arginine on hypoxia and secondary damage. Am J Physiol Renal Physiol. 2003; 284:F338–F348. PMID:
12388385.
43. Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012; 81:442–448. PMID:
22113526.
Article
44. Fine LG, Orphanides C, Norman JT. Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int Suppl. 1998; 65:S74–S78. PMID:
9551436.